BVS – bioventus inc. - class a (US:NASDAQ)

News

Bioventus: A New Start [Seeking Alpha]
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference
Bioventus (NASDAQ:BVS) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.
Bioventus reiterates 2025 guidance with 6%–8% organic growth target as PNS and PRP launches gain traction [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com